John Stirling Meyer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
John Stirling Meyer has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
John Thornby
Biostatistical Laboratories, Veterans Administration Medical Center, Houston, Texas, USA
7 shared publicationsMinh Quach
Cerebrovascular Research, Veterans Administration Medical Center, Houston, Texas, USA
5 shared publicationsMunir Chowdhury
5 shared publications- Gelin Xu
Department of Neurology, Shenzhen Second People's Hospital, China
4 shared publications A Haque
2 shared publicationsG M Rauch
2 shared publications
Latest Publications
- 15 August 2009
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 283 (1-2) , 258
Combined mild diabetes with hypertension during aging increases white matter atrophy
- 15 August 2009
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 283 (1-2) , 258
Combined mild diabetes with hypertension during aging increases white matter atrophy
- 1 December 2005
- Published by Bentham Science Publishers Ltd. in Current Alzheimer Research
- Vol. 2 (5) , 579-585
MRI Abnormalities Associated with Mild Cognitive Impairments of Vascular (VMCI) Versus Neurodegenerative (NMCI) Types Prodromal for Vascular and Alzheimers Dementias
Background and Objectives: Mild Cognitive Impairments (MCIs) are identifiable clinical entities, in neurodegenerative forms, as prodromal for Alzheimers type (DAT) or in vascular forms, as prodromal for vascular dementia (VaD). The present longitudinal study compares and contrasts MRI abnormalities among MCI subjects as they progress to DAT versus VaD. Subjects converting to DAT and VaD confirmed ultimate diagnosis during MCI staging. In "mixed cases" the predominant MRI pathology was judged the primary cause. Subjects and Methods: Subjects (n=153) were selected from elderly outpatient volunteers who have been enrolled for 25 years in planned longitudinal studies of aging, stroke and dementia. Cognitively normal (CN, n=52), MCI of neurodegenerative (N-MCI, n=30) and vascular (V-MCI),n=35) subtypes, plus converted DAT (n=19) and VaD (n=17) were diagnosed according to established protocols. Combined Mini-Mental-Cognitive Capacity Screening Examinations (CMC) screened, identified and confirmed MCIs or dementias. Cerebral MRI abnormalities were analyzed utilizing volumetric measurements and visual rating scales. Results: Compared with persistently cognitively normal subjects, MCI subjects and converted dementias were significantly older without significant gender differences, but cognitively impaired subjects were older than the CN group since age is a risk factor for cognitive decline. Histories of hypertension, heart disease, diabetes mellitus, TIAs and strokes were more frequent among subjects with VMCI and VaD, confirming that all vascular risk factors contribute to vascular cognitive decline, but since vascular risk factors were treated, not all progressed to VAD. Family history of neurodegenerative disease, particularly DAT, were more prevalent among NMCI and converted DAT subjects. VMCI showed more extensive leucoaraiosis and lacunar infarcts than subjects with NMCI. NMCI, prodromal for dementia of Alzheimers type (DAT), showed more medial temporal lobe atrophy with enlarged temporal horns, and fewer vascular lesions.
- 1 December 2005
- Published by Bentham Science Publishers Ltd. in Current Alzheimer Research
- Vol. 2 (5) , 579-585
MRI Abnormalities Associated with Mild Cognitive Impairments of Vascular (VMCI) Versus Neurodegenerative (NMCI) Types Prodromal for Vascular and Alzheimers Dementias
Background and Objectives: Mild Cognitive Impairments (MCIs) are identifiable clinical entities, in neurodegenerative forms, as prodromal for Alzheimers type (DAT) or in vascular forms, as prodromal for vascular dementia (VaD). The present longitudinal study compares and contrasts MRI abnormalities among MCI subjects as they progress to DAT versus VaD. Subjects converting to DAT and VaD confirmed ultimate diagnosis during MCI staging. In "mixed cases" the predominant MRI pathology was judged the primary cause. Subjects and Methods: Subjects (n=153) were selected from elderly outpatient volunteers who have been enrolled for 25 years in planned longitudinal studies of aging, stroke and dementia. Cognitively normal (CN, n=52), MCI of neurodegenerative (N-MCI, n=30) and vascular (V-MCI),n=35) subtypes, plus converted DAT (n=19) and VaD (n=17) were diagnosed according to established protocols. Combined Mini-Mental-Cognitive Capacity Screening Examinations (CMC) screened, identified and confirmed MCIs or dementias. Cerebral MRI abnormalities were analyzed utilizing volumetric measurements and visual rating scales. Results: Compared with persistently cognitively normal subjects, MCI subjects and converted dementias were significantly older without significant gender differences, but cognitively impaired subjects were older than the CN group since age is a risk factor for cognitive decline. Histories of hypertension, heart disease, diabetes mellitus, TIAs and strokes were more frequent among subjects with VMCI and VaD, confirming that all vascular risk factors contribute to vascular cognitive decline, but since vascular risk factors were treated, not all progressed to VAD. Family history of neurodegenerative disease, particularly DAT, were more prevalent among NMCI and converted DAT subjects. VMCI showed more extensive leucoaraiosis and lacunar infarcts than subjects with NMCI. NMCI, prodromal for dementia of Alzheimers type (DAT), showed more medial temporal lobe atrophy with enlarged temporal horns, and fewer vascular lesions.
- 1 March 2005
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 229-230, 121-129
MRI identifies MCI subtypes: vascular versus neurodegenerative
- 1 March 2005
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 229-230, 121-129
MRI identifies MCI subtypes: vascular versus neurodegenerative
- 13 June 2003
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 18 (7) , 609-616
Adapting Mini‐Mental State Examination for dementia screening among illiterate or minimally educated elderly Chinese
Background: Illiteracy is prevalent among current elderly Chinese. There are few brief cognitive tests in Chinese designed to screen those possibly demented for more detailed evaluation in a clinical setting.Objectives: The present study adapted the Mini‐Mental State Examination (MMSE) for screening dementia among illiterate or less educated elderly Chinese.Methods: Literacy‐dependent items of the MMSE were modified or substituted by equivalent items that are not literacy‐dependment. Some items were modified to provide socio‐cultural compatibility. After developing it, the Chinese adapted MMSE (CAMSE) was administered to 370 elderly outpatients from Xijing hospitals located in Xi'an, China, 93 of whom were found to be demented and 277 non‐demented. Sensitivities and specificities for detecting dementia were evaluated by adjusting for different CAMSE cut‐off points. The optimal cut‐off points of 22 for literates and 20 for illiterates yielded a sensitivity of 83.87% and a specificity of 84.48%. Corresponding positive predictive value (PPV) was 0.65, and negative predictive value (NPV) was 0.94. The impact of literacy on CAMSE and individual test items was also evaluated. Illiterate subjects got a higher CAMSE total score than literate subjects (p < 0.05). Only one out of 12 test items, serial sevens, was negatively influenced by illiteracy (p < 0.01). After an interval of 4–6 weeks, 32 randomly selected subjects were retested with CAMSE. The test–retest reliability for total scores was 0.75 (p < 0.01).Conclusions: Results suggest that in the socio‐cultural context for Chinese, irrespective of their literacy skills, CAMSE proved feasible for use in clinical settings for dementia screening. Copyright © 2003 John Wiley & Sons, Ltd.
- 13 June 2003
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 18 (7) , 609-616
Adapting Mini‐Mental State Examination for dementia screening among illiterate or minimally educated elderly Chinese
Background: Illiteracy is prevalent among current elderly Chinese. There are few brief cognitive tests in Chinese designed to screen those possibly demented for more detailed evaluation in a clinical setting.Objectives: The present study adapted the Mini‐Mental State Examination (MMSE) for screening dementia among illiterate or less educated elderly Chinese.Methods: Literacy‐dependent items of the MMSE were modified or substituted by equivalent items that are not literacy‐dependment. Some items were modified to provide socio‐cultural compatibility. After developing it, the Chinese adapted MMSE (CAMSE) was administered to 370 elderly outpatients from Xijing hospitals located in Xi'an, China, 93 of whom were found to be demented and 277 non‐demented. Sensitivities and specificities for detecting dementia were evaluated by adjusting for different CAMSE cut‐off points. The optimal cut‐off points of 22 for literates and 20 for illiterates yielded a sensitivity of 83.87% and a specificity of 84.48%. Corresponding positive predictive value (PPV) was 0.65, and negative predictive value (NPV) was 0.94. The impact of literacy on CAMSE and individual test items was also evaluated. Illiterate subjects got a higher CAMSE total score than literate subjects (p < 0.05). Only one out of 12 test items, serial sevens, was negatively influenced by illiteracy (p < 0.01). After an interval of 4–6 weeks, 32 randomly selected subjects were retested with CAMSE. The test–retest reliability for total scores was 0.75 (p < 0.01).Conclusions: Results suggest that in the socio‐cultural context for Chinese, irrespective of their literacy skills, CAMSE proved feasible for use in clinical settings for dementia screening. Copyright © 2003 John Wiley & Sons, Ltd.
- 3 October 2002
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 17 (11) , 1027-1033
Screening for mild cognitive impairment (MCI) utilizing combined mini‐mental‐cognitive capacity examinations for identifying dementia prodromes
Objective To test correctness of results when combining Mini‐Mental State Examination (MMSE) and Cognitive Capacity Screening Examination (CCSE) for identifying mild cognitive impairment (MCI) among non‐demented elderly subjects at risk for developing dementia. Methods A retrospective study was conducted among consecutively referred volunteers with memory complaints to a research out‐patient clinic. Two cognitive screening tests (MMSE and CCSE) were performed according to established protocol. Resulting combined screening test (termed by acronym as CMC) combined the non‐overlapping test items derived from both MMSE and CCSE. Conversion to dementia at follow‐up served as the ‘gold‐standard’ for evaluating correctness of CMC for identifying MCI. Results Of 351 subjects completing cognitive assessments and meeting requirements for study protocol, 84 (23.9%) developed dementia of different types within 3–6 years (3.89 ± 2.17) of follow‐up. Among these, 47 met criteria for probable Alzheimer disease (AD), 22 for probable vascular dementia (VaD), 12 for mixed AD/VaD and three for probable frontotemporal dementia. When final diagnosis of AD was used as the ‘gold standard’ for testing correctness of MCI identified by cognitive screening tests, sensitivities of MMSE, CCSE and CMC for identifying MCI were relatively 61.0%, 74.3% and 83.1% with minimum specificity set at 80%. When diagnosis of all types of dementia was used as the standard for testing predictive correctness of MCI, CCSE emerged as an optimal MCI screening test. Conclusion Combining the CCSE and MMSE screening tests resulted in higher sensitivity than was achieved by MMSE alone and maintained specificity at comparable levels for identifying MCI. The results confirmed that CMC has optimal correctness and utility as a brief cognitive test for screening MCI as a prodrome for dementia among non‐demented elderly populations. Copyright © 2002 John Wiley & Sons, Ltd.
- 3 October 2002
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 17 (11) , 1027-1033
Screening for mild cognitive impairment (MCI) utilizing combined mini‐mental‐cognitive capacity examinations for identifying dementia prodromes
Objective To test correctness of results when combining Mini‐Mental State Examination (MMSE) and Cognitive Capacity Screening Examination (CCSE) for identifying mild cognitive impairment (MCI) among non‐demented elderly subjects at risk for developing dementia. Methods A retrospective study was conducted among consecutively referred volunteers with memory complaints to a research out‐patient clinic. Two cognitive screening tests (MMSE and CCSE) were performed according to established protocol. Resulting combined screening test (termed by acronym as CMC) combined the non‐overlapping test items derived from both MMSE and CCSE. Conversion to dementia at follow‐up served as the ‘gold‐standard’ for evaluating correctness of CMC for identifying MCI. Results Of 351 subjects completing cognitive assessments and meeting requirements for study protocol, 84 (23.9%) developed dementia of different types within 3–6 years (3.89 ± 2.17) of follow‐up. Among these, 47 met criteria for probable Alzheimer disease (AD), 22 for probable vascular dementia (VaD), 12 for mixed AD/VaD and three for probable frontotemporal dementia. When final diagnosis of AD was used as the ‘gold standard’ for testing correctness of MCI identified by cognitive screening tests, sensitivities of MMSE, CCSE and CMC for identifying MCI were relatively 61.0%, 74.3% and 83.1% with minimum specificity set at 80%. When diagnosis of all types of dementia was used as the standard for testing predictive correctness of MCI, CCSE emerged as an optimal MCI screening test. Conclusion Combining the CCSE and MMSE screening tests resulted in higher sensitivity than was achieved by MMSE alone and maintained specificity at comparable levels for identifying MCI. The results confirmed that CMC has optimal correctness and utility as a brief cognitive test for screening MCI as a prodrome for dementia among non‐demented elderly populations. Copyright © 2002 John Wiley & Sons, Ltd.
- 1 August 2002
- Published by Wolters Kluwer Health in Stroke
- Vol. 33 (8) , 1981-1985
Is Mild Cognitive Impairment Prodromal for Vascular Dementia Like Alzheimer’s Disease?
Background and Purpose — Individuals with mild cognitive impairment (MCI) are at increased risk of Alzheimer’s disease (AD) and probably other forms of dementia. Some subtypes of vascular dementia (VaD) may possess minor neuropathological changes of AD that may contribute to cognitive impairments. It was posited that MCI, identified by criteria described here, might present as a prodrome for VaD and AD. Methods — Serial Mini-Mental State Examination was administered at 3- to 6-month intervals, and neuroimaging was performed annually. Subtle cognitive dysfunctions were weighted and measured according to MCI criteria defined here. Subjects identified with MCI were then followed up for an additional 3.88±3.01 years. Diagnoses of VaD and AD were made according to established criteria. Results — During 3.72±2.94 years of follow-up of the original normative subjects, 73 of 291 (25.1%) developed MCI. Of the 27 subjects who developed VaD, 15 (55.6%) had prodromal MCI. Of these, two thirds were subclassified as having small-vessel dementia. The remaining 12 patients with VaD (44.4%) were diagnosed directly from a cognitively normal status without preceding MCI. These were predominantly multi-infarct or strategic-infarct dementia (66.7%). An additional 35 MCI subjects (47.9%) developed AD. Both VaD and AD diagnosed after MCI prodromes manifested similar spectral domains of cognitive impairments, which included memory, during their MCI stages. Conclusions — In some VaD subtypes, particularly those caused by subcortical microvascular disease, dementia may be preceded by MCI, which has similar domains of cognitive impairment and a similar progressive course that may mimic AD.
- 1 August 2002
- Published by Wolters Kluwer Health in Stroke
- Vol. 33 (8) , 1981-1985
Is Mild Cognitive Impairment Prodromal for Vascular Dementia Like Alzheimer’s Disease?
Background and Purpose — Individuals with mild cognitive impairment (MCI) are at increased risk of Alzheimer’s disease (AD) and probably other forms of dementia. Some subtypes of vascular dementia (VaD) may possess minor neuropathological changes of AD that may contribute to cognitive impairments. It was posited that MCI, identified by criteria described here, might present as a prodrome for VaD and AD. Methods — Serial Mini-Mental State Examination was administered at 3- to 6-month intervals, and neuroimaging was performed annually. Subtle cognitive dysfunctions were weighted and measured according to MCI criteria defined here. Subjects identified with MCI were then followed up for an additional 3.88±3.01 years. Diagnoses of VaD and AD were made according to established criteria. Results — During 3.72±2.94 years of follow-up of the original normative subjects, 73 of 291 (25.1%) developed MCI. Of the 27 subjects who developed VaD, 15 (55.6%) had prodromal MCI. Of these, two thirds were subclassified as having small-vessel dementia. The remaining 12 patients with VaD (44.4%) were diagnosed directly from a cognitively normal status without preceding MCI. These were predominantly multi-infarct or strategic-infarct dementia (66.7%). An additional 35 MCI subjects (47.9%) developed AD. Both VaD and AD diagnosed after MCI prodromes manifested similar spectral domains of cognitive impairments, which included memory, during their MCI stages. Conclusions — In some VaD subtypes, particularly those caused by subcortical microvascular disease, dementia may be preceded by MCI, which has similar domains of cognitive impairment and a similar progressive course that may mimic AD.
- 28 May 2002
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 17 (6) , 586-588
Feasibility of treating mild cognitive impairment withcholinesterase inhibitors
- 28 May 2002
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 17 (6) , 586-588
Feasibility of treating mild cognitive impairment withcholinesterase inhibitors
- 16 July 2001
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 16 (7) , 718-727
Longitudinal follow‐up of depressive symptoms among normal versus cognitively impaired elderly
Objectives: This prospectively designed longitudinal study assesses prevalence, incidence and prognosis of depressive symptoms among cognitively normal elderly volunteers compared with patients with mild cognitive impairment (MCI), dementia of Alzheimer type (DAT), and vascular dementia (VAD). Possible relationships between depressive symptoms, cognitive performance, disease types, and effects of antidepressant treatment were analyzed.Methods: Two hundred and ninety four subjects exhibiting different levels of cognitive performance were admitted to this study. Demographics, cardiovascular and neurodegenerative risk factors, together with measures of neuropsychological test performance, were obtained at sequential visits. Depressive symptoms were selectively treated with antidepressant medications.Results: One hundred and forty six subjects with normal cognition, 19 subjects with MCI, 42 patients with DAT, and 32 patients with VAD were followed for a mean of 3.5 years. With the passage of time, there were trends showing prevalence of depressive symptoms to decrease among DAT and to increase among VAD patients. VAD patients exhibited the highest incidences of new‐onset depressive symptoms, followed in incidence by DAT and MCI groups. Depressive symptoms among VAD and MCI patients were more persistent and refractory to antidepressant medications than for DAT patients. Trends suggested that antidepressant treatment might benefit MCI and VAD subjects more than DAT patients. Motivationally related depressive symptoms accounted for major components of elevated Hamilton depression rating scale scores.Conclusions: Depressive symptoms among DAT patients have higher rates of spontaneous resolution, without requiring intensive drug treatment, than among VAD patients in whom depressive symptoms are more persistent and refractory to drug treatment. Early depressive symptoms among subjects with MCI may represent a preclinical sign and should be considered as a risk factor for impending DAT or VAD among the elderly. Copyright © 2001 John Wiley & Sons, Ltd.
- 16 July 2001
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 16 (7) , 718-727
Longitudinal follow‐up of depressive symptoms among normal versus cognitively impaired elderly
Objectives: This prospectively designed longitudinal study assesses prevalence, incidence and prognosis of depressive symptoms among cognitively normal elderly volunteers compared with patients with mild cognitive impairment (MCI), dementia of Alzheimer type (DAT), and vascular dementia (VAD). Possible relationships between depressive symptoms, cognitive performance, disease types, and effects of antidepressant treatment were analyzed.Methods: Two hundred and ninety four subjects exhibiting different levels of cognitive performance were admitted to this study. Demographics, cardiovascular and neurodegenerative risk factors, together with measures of neuropsychological test performance, were obtained at sequential visits. Depressive symptoms were selectively treated with antidepressant medications.Results: One hundred and forty six subjects with normal cognition, 19 subjects with MCI, 42 patients with DAT, and 32 patients with VAD were followed for a mean of 3.5 years. With the passage of time, there were trends showing prevalence of depressive symptoms to decrease among DAT and to increase among VAD patients. VAD patients exhibited the highest incidences of new‐onset depressive symptoms, followed in incidence by DAT and MCI groups. Depressive symptoms among VAD and MCI patients were more persistent and refractory to antidepressant medications than for DAT patients. Trends suggested that antidepressant treatment might benefit MCI and VAD subjects more than DAT patients. Motivationally related depressive symptoms accounted for major components of elevated Hamilton depression rating scale scores.Conclusions: Depressive symptoms among DAT patients have higher rates of spontaneous resolution, without requiring intensive drug treatment, than among VAD patients in whom depressive symptoms are more persistent and refractory to drug treatment. Early depressive symptoms among subjects with MCI may represent a preclinical sign and should be considered as a risk factor for impending DAT or VAD among the elderly. Copyright © 2001 John Wiley & Sons, Ltd.
- 21 May 2001
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 16 (5) , 455-461
Depressive symptoms among cognitively normal versus cognitively impaired elderly subjects
Objectives: The present cross‐sectional study analyzed the prevalence and severity of depressive symptoms among patients with Alzheimer's disease (DAT), vascular dementia (VAD), and among the cognitively normal elderly. Putative risk factors contributing to depression were likewise evaluated.Methods: Seventy‐six DAT patients, 51 VAD patients, and 121 cognitively normal subjects were admitted to the study. Questionnaires concerning demography and their vascular and familial risk factors together with results of neuropsychological testing by combined Mini‐Mental Status Examinations (MMSE), Cognitive Capacity Screening Examinations (CCSE), and Hamilton Depression Rating Scales (HDRS) were obtained so that resulting data would be statistically analyzed.Results: Prevalence of depressive symptoms among VAD, DAT, and cognitively normal elderly were 31.4%, 19.9%, and 13.2%, respectively. 25.5% of VAD and 13.2% of DAT patients had depression of mild to moderate degrees. Regression analysis revealed that diagnosis of VAD and DAT, heart disease, and past history of depression was significantly associated with high HDRS scores. There was no correlation between degree of depression and severity of cognitive impairments.Conclusion: Mild to moderate depression is a common comorbidity with organic dementia, especially VAD, but associated depression is independent of severity of cognitive impairments. Copyright © 2001 John Wiley & Sons, Ltd
- 21 May 2001
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 16 (5) , 455-461
Depressive symptoms among cognitively normal versus cognitively impaired elderly subjects
Objectives: The present cross‐sectional study analyzed the prevalence and severity of depressive symptoms among patients with Alzheimer's disease (DAT), vascular dementia (VAD), and among the cognitively normal elderly. Putative risk factors contributing to depression were likewise evaluated.Methods: Seventy‐six DAT patients, 51 VAD patients, and 121 cognitively normal subjects were admitted to the study. Questionnaires concerning demography and their vascular and familial risk factors together with results of neuropsychological testing by combined Mini‐Mental Status Examinations (MMSE), Cognitive Capacity Screening Examinations (CCSE), and Hamilton Depression Rating Scales (HDRS) were obtained so that resulting data would be statistically analyzed.Results: Prevalence of depressive symptoms among VAD, DAT, and cognitively normal elderly were 31.4%, 19.9%, and 13.2%, respectively. 25.5% of VAD and 13.2% of DAT patients had depression of mild to moderate degrees. Regression analysis revealed that diagnosis of VAD and DAT, heart disease, and past history of depression was significantly associated with high HDRS scores. There was no correlation between degree of depression and severity of cognitive impairments.Conclusion: Mild to moderate depression is a common comorbidity with organic dementia, especially VAD, but associated depression is independent of severity of cognitive impairments. Copyright © 2001 John Wiley & Sons, Ltd
- 26 April 2001
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 16 (4) , 430-435
Validating mini‐mental status, cognitive capacity screening and Hamilton depression scales utilizing subjects with vascular headaches
Introduction: The Mini‐Mental State Examination (MMSE) and Cognitive Capacity Screening Examination (CCSE) are easily and rapidly administered tests for quantifying the general cognitive status of young as well as geriatric subjects. Likewise, the Hamilton Depression Rating Scale (HDRS) is a brief instrument for quantifying depression that may confound cognitive test performances. Testing by means of all three scales concurrently provides useful information for longitudinal research among the elderly.Objectives: To validate the combined longitudinal use of MMSE, CCSE and HDRS among a specific cohort of normal subjects with vascular headaches characterized by known well‐established temporary cognitive decline occurring only during temporary intervals with headache.Methods: The MMSE, CCSE and HDRS were serially tested at 3–12 monthly intervals among 196 healthy subjects attending our out‐patient headache clinic who suffered from migraine or cluster headaches. Stability and specificity of MMSE, CCSE and HDRS were evaluated by comparing consecutive normative scores during headache‐free intervals. Sensitivity of MMSE and CCSE for detecting temporary cognitive decline were evaluated by comparing scores during headache and headache‐free intervals.Results: CCSE, MMSE and HDRS gave stable headache‐free normative values over intervals of 3–10 years among 182 subjects. Among 77 subjects during headache intervals, temporary cognitive decline were confirmed by both CCSE and MMSE (p < 0.0001). When cutoff points for both CCSE and MMSE normal scores were placed at ≥ 27, specificity for detecting cognitively normal values for CCSE and MMSE when headache‐free were 92.2 and 89.6%, respectively (p > 0.05), while sensitivity for detecting cognitively decline during headache intervals were 83.7 and 49%, respectively (p < 0.001). Compared with scoring by a single rater, reliability estimates for all three rating scales were slightly lower when tested by different raters, but these differences were not significant.Conclusions: CCSE is reliable and more sensitive than MMSE for detecting cognitive decline. Copyright © 2001 John Wiley & Sons, Ltd.
- 26 April 2001
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 16 (4) , 430-435
Validating mini‐mental status, cognitive capacity screening and Hamilton depression scales utilizing subjects with vascular headaches
Introduction: The Mini‐Mental State Examination (MMSE) and Cognitive Capacity Screening Examination (CCSE) are easily and rapidly administered tests for quantifying the general cognitive status of young as well as geriatric subjects. Likewise, the Hamilton Depression Rating Scale (HDRS) is a brief instrument for quantifying depression that may confound cognitive test performances. Testing by means of all three scales concurrently provides useful information for longitudinal research among the elderly.Objectives: To validate the combined longitudinal use of MMSE, CCSE and HDRS among a specific cohort of normal subjects with vascular headaches characterized by known well‐established temporary cognitive decline occurring only during temporary intervals with headache.Methods: The MMSE, CCSE and HDRS were serially tested at 3–12 monthly intervals among 196 healthy subjects attending our out‐patient headache clinic who suffered from migraine or cluster headaches. Stability and specificity of MMSE, CCSE and HDRS were evaluated by comparing consecutive normative scores during headache‐free intervals. Sensitivity of MMSE and CCSE for detecting temporary cognitive decline were evaluated by comparing scores during headache and headache‐free intervals.Results: CCSE, MMSE and HDRS gave stable headache‐free normative values over intervals of 3–10 years among 182 subjects. Among 77 subjects during headache intervals, temporary cognitive decline were confirmed by both CCSE and MMSE (p < 0.0001). When cutoff points for both CCSE and MMSE normal scores were placed at ≥ 27, specificity for detecting cognitively normal values for CCSE and MMSE when headache‐free were 92.2 and 89.6%, respectively (p > 0.05), while sensitivity for detecting cognitively decline during headache intervals were 83.7 and 49%, respectively (p < 0.001). Compared with scoring by a single rater, reliability estimates for all three rating scales were slightly lower when tested by different raters, but these differences were not significant.Conclusions: CCSE is reliable and more sensitive than MMSE for detecting cognitive decline. Copyright © 2001 John Wiley & Sons, Ltd.